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Abstract
Background: Glycolipids are one component of cell membranes, and are found most prevalently
at the surface of the plasma membrane. Animal cells take in amphipathic glycosides, which are later
glycosylated after assimilation in biosynthetic pathways. Gycosylated glycosides are released
outside of cells to the surrounding culture medium. This represents an accessible method of
obtaining complex glycosides.
Results:  Vero cells are sensitive to Shiga toxins and are known to express the glycosides
globotriaosyl ceramide (Gb3) and globotetraosyl ceramide (Gb4) on the surface of the plasma
membrane. By administering amphipathic lactosides to Vero cells, the above mentioned glycolipids
could be produced by the action of cellular enzymes. In our study, the optimum conditions (seeded
cell number, incubated time period, 12-azidododecyl lactoside concentration and medium volume)
for the production of Gb3 analogue were investigated. The 87.9 µg/100 mm dish (11.7 % yield) Gb3
analogue was produced under appropriate conditions. The large-scale culture of Vero cells using a
microcarrier culture method with repetitions produced about 30 mg of the Gb3 analogue.
Conclusion: The mass production of glycosides in Vero cells was carried out on a microcarrier
with repeated administration of 12-azidododecyl lactoside. The results indicated that the use of
both a microcarrier culture and repetition were highly effective in the production of Gb3, Gb4 and
sialyl lactoside (GM3) type-oligosaccharides.
Background
Glycolipids are one component of cell membranes, and
are found most prevalently at the surface of the plasma
membrane. They serve as signal molecules, being recog-
nized by proteins such as lectins, bacterial toxins and
viruses [1].
Glycolipids are composed of a ceramide and a sugar moi-
ety synthesized in the endoplasmic reticulum (ER) and
Golgi apparatus, respectively. Lactosyl ceramide is one
precursor of complex glycolipids and can be glycosylated
in the Golgi. Glycolipids prepared biosynthetically are
then transported to the plasma membrane where they
remain as components of cell membrane [2,3]. These
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pathways have been utilized to produce oligosaccharides
using cellular enzymes or recombinant cells [4-6].
The commonest method of preparing glycosides is by
chemical synthesis. However, many reports show that this
preparation of glycosides is difficult, requiring several
reaction steps and control of stereoselectivity of the glyco-
syl linkage. [7,8].
B16 melanoma cells strongly express sialyl lactosyl cera-
mide (GM3) at the surface of the plasma membrane. It
has been reported that hexadecyl β-lactoside is sialylated
in B16 cells. Therefore, B16 cells take in amphipathic lac-
tosides dissolved in the culture medium and sialylated
them, before releasing them into the surrounding culture
medium. This method for the production of glycolipid
analogues can be applied to various cells and alkyl glyco-
sides [9,10].
When amphipathic glycosides with different sugar units
are taken into a cell, the glycosides are further glycosylated
by a variety of cellular enzymes resulting in various oli-
gosaccharides. To ensure glycosylation of amphipathic
glycosides, a series of requirements must be satisfied: First,
the glycoside must be taken into the cell. Here the length
of the alkyl chain of the aglycon is important; glycosides
with C8 alkyl chains are taken in by B16 cells poorly,
while those with C12 or C16 alkyl chains enter more effi-
ciently. Second, the glycoside should be recognized by cel-
lular enzymes. Third, the glycosylated product should be
released to the culture medium; the elongated glycosides
with C16 alkyl chains have been shown to remain mostly
in the B16 cell, whilst those with C12 chains are released
into culture medium [11].
In this study, we report the glycosylation of dodecyl lacto-
side or 12-azidododecyl lactoside in Vero cells. The pro-
duction of the globotriaosyl ceramide (Gb3) analogue
was optimized using appropriate conditions such as
seeded cell number, concentration of the lactoside, time
of incubation and culture medium volume. The adminis-
tration of the lactoside and harvesting of glycosylated lac-
toside were repeated every 24 to 72 hours for twelve days.
Because obtaining glycosylated product in large amounts
on culture dishes is tedious, the efficient mass production
of Gb3 analogue was accomplished using Vero cells cul-
tured on microcarriers in spinner flasks. As compared to
existing methods of production of Gb3 analogues, our
method is fast and convenient, and does not require the
use of expensive enzymes and glycosyl donor. In addition,
controlling the stereoselectivity of the product is not a
problem.
Results and discussion
Chemical synthesis of amphipathic glycosides
Dodecyl lactoside is the standard used to investigate glyc-
osylation in cells. We prepared dodecyl β-acetyl lactoside
by reacting acetyl lactosyl imidate with dodecane-1-ol
using BF3·Et2O (scheme 1). The dodecyl β-acetyl lactos-
ide was then deacetylated with NaOMe in MeOH, with
the amphipathic glycoside, dodecyl β-lactoside, obtained
in a 51.6% yield (2 steps).
Scheme 1: Synthesis of amphipathic lactosides. i) NaN3, DMSO, 80°C. 
ii) BF3·Et2O, ClCH2CH2Cl, 0°C. iii) NaOMe, MeOH, r.t.
We also synthesized 12-azidododecyl lactoside. 12-
Bromo dodecane-1-ol was reacted with sodium azide in
DMSO yielding 12-azidododecane-1-ol, which was then
glycosylated with lactosyl imidate by the same procedure,
before being deacetylated to give 12-azido dodecyl lactos-
ide in 61.3% yield (3 steps). The product has the azido
group at the ω-position of the alkyl chain, which can be
easily converted to an amino group for further utilization.
Glycosylation of dodecyl lactoside by Vero cells
To investigate how the amphiphatic lactoside is glyco-
sylated, dodecyl lactoside was incubated with Vero cells.
After incubation, the glycolipids – which were collected
from the culture medium and cell homogenates – were
analyzed by HPTLC. As shown in Figure 1 (A), three new
bands, which were not obtained in the control, were
observed. It was thought likely that these corresponded to
Gb3, Gb4 and GM3 type oligosaccharides, owing to these
being known to occur naturally in Vero cells [12-15].
To determine the structure of the glycosylated sugar moi-
ety, the glycosylated lactosides were scraped from the
HPTLC plates, collected and extracted. Owing to the small
quantities of collected glycosides NMR spectra could not
be measured; analysis was thus carried out by ESI-MS. The
mass spectra results showed peaks at m/z 533.4, 695.1,
898.5 and 987.7 corresponding to [dodecyl lactoside +
Na]+, [dodecyl Gb3 + Na]+, [dodecyl Gb4 + Na]+ and
[dodecyl GM3 + Na]+, respectively. These results are con-
sistent with the glycosides anticipated from HPTLC analy-
ses. The three new bands were thus assumed to be
analogues of Gb3 (galactosylated lactoside derivative),
Gb4 and GM3. These oligosaccharides were produced by
only one cell type, therefore, different kinds of oligosac-
charides can be produced using various cells. This method
of administering the glycosides to the cells is also effective
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in biocombinatorial synthesis for the construction of an
oligosaccharide library [16].
In the same manner, 12-azidododecyl lactoside was incu-
bated with Vero cells and the glycosides in the culture
medium were developed on HPTLC. From HPTLC analy-
sis, three new bands were observed (at same positions
observed for dodecyl lactoside) and corresponding to
Gb3, Gb4 and GM3.
Influence of seeded cell number
To evaluate the influence of seeded cell number on the
yield of glycosylated lactoside, 2 × 106, 5 × 106 and 10 ×
106 Vero cells were seeded on 100 mm dishes. The seeded
cells were incubated for 24 h in a medium containing
10% FBS before being incubated in a medium containing
50 µM of 12-azidododecyl lactoside for a further 48 h.
Quantification of the amount of glycosylated product
with a densitometer revealed that the relative ratio of the
absorbances of the galactosylated lactoside bands was
1.00 (2 × 106 cells): 1.39 (5 × 106 cells): 1.74 (10 × 106
cells) as shown in Figure 2 (A). Therefore, the quantity of
glycosylated product increased with increasing seeded cell
number, with 2 × 106 cells most efficient for the quantity
of product obtained per-cell.
Influence of the incubation time
To evaluate the influence of incubation time on the yield
of glycosylated lactoside, 2 × 106 Vero cells were seeded on
100 mm dishes. The cells were incubated in a medium
containing 10% FBS for 24 h, before further incubation
for 48, 72 and 96 h in a medium containing 50 µM 12-azi-
dododecyl lactoside. Analysis of the amount of glyco-
sylated product with a densitometer revealed that the
relative ratio of the absorbances of the galactosylated lac-
toside bands was 1.00 (48 h): 1.78 (72 h): 1.84 (96 h) as
shown in Figure 2 (B). An incubation time of 72 h was
most efficient in terms of the amount of product obtained
as a function of time.
Influence of the concentration of 12-azidododecyl 
lactoside
To evaluate the influence of the concentration of 12-azido
dodecyl lactoside on the yield of glycosylated lactoside, 2
× 106 Vero cells were seeded on 100 mm dishes and incu-
bated in a medium containing 10% FBS for 24 h. Subse-
quently, the dishes were incubated in media containing
50, 100, 150 and 200 µM of 12-azidododecyl lactoside for
48 h. Quantification of the amount of glycosylated prod-
uct with a densitometer revealed that the relative ratio of
the absorbances of galactosylated lactoside band was 1.00
(50 µM): 1.46 (100 µM): 1.54 (150 µM): 1.17 (200 µM)
as shown in Figure 2 (C). The largest amount of galactos-
ylated lactoside was obtained from the incubation with
150 µM of lactoside, while cytotoxicity was observed for
the 200 µM medium (See additional file 1: Figure 4). The
medium containing 50 µM of lactoside was seen to be the
most efficient in terms of the yield of galactosylated lacto-
side.
Influence of medium volume
To evaluate the influence of media volume on the yield of
glycosylated lactoside, 5 × 106 Vero cells were seeded on
100 mm dishes. The cells were incubated in a medium
containing 10% FBS for 24 h, before incubation for 48 h
in 7.0, 10.5, 14 and 35 ml of media containing 50 µM 12-
azidododecyl lactoside. Analysis with a densitometer of
the quantity of glycosylated product revealed that the rel-
ative ratio of the absorbances of galactosylated lactoside
bands was 1.00 (7 ml): 1.59 (10.5 ml): 1.42 (14 ml): 1.63
(35 ml) as shown in Figure 2 (D). Even if the volume of
the medium were increased, the yields of galactosylated
lactoside were almost similar to those obtained from 10.5
ml. Therefore, the 10.5 ml medium was deemed most
suitable for the production of glycoside.
The quantity of galactosylated lactoside obtained under 
optimum conditions
We selected the following conditions: seeded cell number
of 5 × 106 or 10 × 106 cells; 72 h incubation period; lacto-
side concentration of 100 or 150 µM; and medium vol-
ume of 10.5 ml. Under these conditions, Vero cells were
seeded on 100 mm dishes and incubated in media con-
taining lactoside (See additional file 2: Figure 5). The
results showed that the highest yield of galactosylated lac-
toside obtained was 87.9 µg/dish (11.7 %). From the
results, the optimum set of conditions were seen to be a
HPTLC results Figure 1
HPTLC results. (A) Glycolipids after incubation of Vero cells 
with dodecyl lactoside. Lane 1, glycolipids extracted from cell 
homogenate; Lane 2, glycolipids extracted from medium; 
Lane 3, dodecyl lactoside. (B) Glycolipids after incubation of 
Vero cells with 12-azidododecyl lactoside. Lane 1, glycolipids 
extracted from cell homogenate; Lane 2, glycolipids 
extracted from medium; Lane 3, 12-azidododecyl lactoside.Chemistry Central Journal 2007, 1:26 http://journal.chemistrycentral.com/content/1/1/26
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72 h incubation period, using 5 × 106 cells in the presence
of 100 µM lactoside and 10.5 ml of medium solution.
Repeated administration and harvest
After the solution containing galactosylated lactoside
derivative was harvested from the medium of Vero cells,
the lactoside-containing medium was successively added
and incubated. The concentration of lactoside in the
media was 100 µM, with the administration and harvest
carried out every 24, 48 or 72 h. The time period of the cell
culture was twelve days, with the amounts of galactos-
ylated lactoside from each of harvested media quantified
using densitometer (Figure 3).
In the case of the 24, 48 and 72 h cycles, the total quanti-
ties of galactosylated lactoside obtained were 430 µg (602
nmol, 5.21%), 371 µg (520 nmol, 8.25%) and 347 µg
(486 nmol, 11.6%), respectively.
These results indicated that Vero cells are suitable for con-
tinuous culture over long, repeated time periods and are
useful for the mass production of glycosides.
Large-scale production of galactosylated lactoside
For the production of large amounts of galactosylated lac-
toside, Vero cells were seeded on a microcarrier in a spin-
ner flask and cultured for 2 weeks [17,18]. The
concentration of lactoside was 100 µM and repetition
cycles lasted 48 or 72 h. The results showed that a 48 h
repetition time frame (rather than 72 h) was preferable,
with Gb3 quantities obtained being 4.7 µg/ml 3.3 µg/ml
for 48 and 72 h, respectively. Finally, Vero cells on a
microcarrier in 4 litre spinner flask were incubated for 48
Influence of cell culture conditions Figure 2
Influence of cell culture conditions. Relative ratio of the amount of product in different (A) seeded cell numbers; (B) incubation 
times; (C) lactoside concentrations; and (D) medium volumes.Chemistry Central Journal 2007, 1:26 http://journal.chemistrycentral.com/content/1/1/26
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h, with the administration and harvest repeated 5 times.
The total amount of galactosylated lactoside obtained was
30.2 mg (42.4 µmol, 1H NMR spectrum: H-1, J1,2 = 7.8; H-
1', J1',2' = 7.2; H-1", J1",2" = 4.2).
Conclusion
We have shown that dodecyl lactoside and 12-azidodo-
decyl lactoside were taken into Vero cells, glycosylated by
cellular enzymes, and released as glycosylated lactosides
into the surrounding medium. The glycosylated lactosides
were identified as Gb3, Gb4 and GM3-type oligosaccha-
rides. The optimum conditions for the production of gly-
cosylated lactosides were determined (seeded cell number
of 5 × 106; 72 h incubation period; lactoside concentra-
tion of 100 µM; medium volume of 10.5 ml) with galac-
tosylated lactoside obtained in 11.6% yield. The lactoside
was repeatedly administered and harvested, continued for
twelve days. The large-scale production of glycosides in
Vero cells was carried out on a microcarrier, resulting in
the production of about 30 mg of product. Results indi-
cated that both a microcarrier culture and repetition were
highly effective for the production of glycosides, such as
Gb3, Gb4 and GM3 type oligosaccharides.
Experimental
General methods
1H NMR spectra were recorded at 600 MHz using a Jeol
ECP-600 spectrometer in chloroform-d  or deuterium
oxide. 13C NMR spectra were recorded at 150.9 MHz with
the same instrument. Tetramethylsilane (TMS) was used
as the internal standard. Assignments in the NMR spectra
were made by first-order analysis of spectra, and sup-
ported by correlation spectroscopy and heteronuclear
chemical shift correlation. Reactions were monitored by
thin-layer chromatography (TLC) on a precoated plate of
silica gel 60 F254 (layer thickness, 0.25 mm; E. Merk,
Darmstadt, Germany). TLC sheets were dipped in (a) a
solution of 85:10:5 (v/v/v)-methanol-p-anisaldehyde-
concentrated sulfuric acid and heated for a few minutes
(for carbohydrates). Column chromatography was per-
formed on silica gel (Silica Gel 60; 40–63 mm, E. Merck,
or Silica Gel 60, spherical neutral; 40–100 mm, E. Merck).
Synthesis of amphipathic glycosides
12-azidodecane-1-ol (1)
To a solution of 12-bromo dodecane-1-ol (12.6 g, 47.4
mmol) indimethyl sulfoxide (200 ml) was added sodium
azide (15.4 g, 237 mmol), with the solution stirred at
80°C for 1 week. The mixture was then extracted with
ethyl acetate, washed with water three times, dried over
Na2SO4, and filtered, with the filtrate evaporated in vacuo.
Purification by silica gel column chromatography with
10:1 (v/v) of hexane:ethyl acetate was carried out on the
residue yielding crude 1 (11.5 g):1H NMR (CDCl3) δ 3.61
(t, 2H, -CH2-O), 3.24 (t, 2H, -CH2-N3), 1.57 (m, 4H, -
CH2-C-O, -CH2-C-N3), 1.27 (m, 16H, -CH2-).
Dodecyl β-lactoside (3)
Compound 3 was prepared by the method described in
the literature [1,6,19]: 1H NMR (H2O) δ 4.19 (d, 1H, J1',2'
= 6.1, H-1'), 4.16 (d, 1H, J1,2 = 7.7, H-1), 3.73 (br-d, 1H, -
O-CH-C-), 3.37 (m, 1H, H-2'), 2.99 (br-t, 1H, H-2), 3.37
(br-d, 1H, -O-CH-C-), 1.50 (s, 2H, -O-C-CH2-), 1.23 (s,
20H, -CH2-), 0.85 (s, 3H, -CH3).
12-Azidododecyl β-lactoside (4)
Compound 4 was prepared by the method described in
the literature [1,6,19]: 1H NMR (H2O) δ 4.87 (d, 1H, J1',2'
= 7.7, H-1'), 4.76 (d, 1H, J1,2 = 7.7, H-1), 2.00 (s, 4H, -O-
C-CH2-, -CH2-C-N3), 1.77 (s, 18H, -CH2-).
Cell culture
Vero Cells were obtained from Riken Cell Bank (Tsukuba,
Japan). DMEM/F12 was purchased from Sigma and fetal
bovine serum (FBS) was purchased from JRH Biosciences.
Insulin-transferrin-sodium selenite-X (ITSX) was pur-
chased from GIBCO. Sep-Pak C18 was purchased from
Waters. HPTLC (silica gel 60) plate (E. Merck, Darmstadt,
Germany) was used. The quantification of glycosylated
products was carried out with CS-9300PC dual-wave-
length flyingspot scanning densitometer (SHIMADZU).
Vero cells were cultured in DMEM/F12 supplemented
with 10% FBS, detached through application of 0.25%
trypsin/EDTA and maintained in humidified atmosphere
of 5% CO2 at 37°C. Cells were cultured in 100 mm dishes.
The lactosides were dissolved in Me2SO to an initial con-
centration of 50 mM.
Galactosylated lactoside (Gb3) produced after repeated  administration of 12-azidododecyl lactoside in Vero cells  with harvest of incubated medium at repeated time periods Figure 3
Galactosylated lactoside (Gb3) produced after repeated 
administration of 12-azidododecyl lactoside in Vero cells 
with harvest of incubated medium at repeated time periods.Chemistry Central Journal 2007, 1:26 http://journal.chemistrycentral.com/content/1/1/26
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Production of elongated glycolipids by Vero cell
2 × 106, 5 × 106 or 10 × 106 Vero cells were seeded on 100
mm culture dishes containing 7, 10.5, 14 or 35 ml of
medium (DMEM/F12 containing 10% FBS) and incu-
bated for 24 h. The cells were then washed with the
medium (DMEM/F12 containing 1% ITSX), and incu-
bated with 50, 100, 150 or 200 µM lactoside. After incu-
bation at 37°C for 48, 72 or 96 h, the culture media were
collected and the cells were washed with PBS (-), har-
vested with 0.25% EDTA in PBS (-), and the suspension
centrifuged at 1000 rpm for 5 min. Lipid extraction was
carried out according to the literature [20]. Lipids from the
cell homogenate and culture medium fractions were ana-
lyzed by HPTLC with 5:4:1 CHCl3-MeOH-0.25% aq KCl
as developing solvent. For identification of elongated gly-
cosides, the bands of products were scraped and the prod-
ucts extracted with methanol. The solutions were then
concentrated and the molecular weights measured using
ESI-MS (Bruker Daltonics Inc., Esquire 6000). For the
quantification of elongated glycosides, HPTLC plates were
sprayed with resorcinol and heated to detect the separated
glycolipids. The bands of glycolipids were measured,
absorbance (410 nm), using a densitometer and quanti-
fied by applying a standard curve of five concentrations of
hexenyl Gb3.
Microcarrier culture
5 g of CELL YARD™ beads (Pentax Co.) were equilibrated
in 100 ml medium and placed in a spinner flask (Shibata
scientific technology ltd). 5 × 107 cells were seeded on the
beads in the flask. The suspension was stirred for 1 minute
at 37 rpm every hour. After 4 h, a medium containing 10%
FBS was added and stirred continually for 2 days at 37
rpm, 37°C. The medium was then changed to one con-
taining 1% ITSX and 100 µM of the 12-azidododecyl lac-
toside and incubation continued. The harvest and
administration were carried out repeatedly and the col-
lected media were treated according to the same method
as described earlier.
The glycolipids could be extracted and purified from the
collected culture media by reversed phase column chro-
matography (octadecyl) using methanol/water (gradient)
as eluent. A more detailed discussion of the purification
method employed in this research will be reported else-
where by Kato et al [21].
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